Filing metadata

Accession number
0001209191-20-021187
Form type
Form 4
Filer
NGM BIOPHARMACEUTICALS INC
CIK
CIK 1426332
Filed
Mar 25, 2020
Reporting period
Mar 23, 2020
Description
Insider transaction

Explore SEC Filings Hub